Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1969-1977
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1969
Table 3 Univariate and multivariate analysis of overall survival and disease-free survival
VariableOverall survival
Disease-free survival
Univariable analysis
Multivariate analysis
Univariable analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
HR (95%CI)
P value
HR (95%CI)
P value
Age (> 65/≤ 65 yr)2.830 (0.983-8.150)0.0542.378 (0.793-7.128)0.1222.048 (0.779-5.384)0.1461.869 (0.674-5.188)0.230
Gender (male/female)1.051 (0.382-2.894)0.9231.180 (0.436-3.191)0.744
CEA level (> 5/≤ 5)1.278 (0.389-4.198)0.6861.098 (0.348-3.465)0.873
CA19-9 level (> 37/≤ 37)1.951 (0.506-7.521)0.3321.304 (0.285-5.958)0.732
ASA physical status (III/I-II)2.565 (0.817-8.050)0.1062.280 (0.655-7.940)0.195
Tumor differentiation (poor/well- moderate)0.918 (0.340-2.478)0.8661.119 (0.431-2.906)0.817
Tumor size (> 5/≤ 5 cm) 1.058 (0.383-2.920)0.9130.863 (0.328-2.269)0.764
T stage (T3-T4/T1-T2)0.994 (0.130-7.627)0.9941.302 (0.172-9.854)0.798
N stage (N1-N2/N0)11.266 (1.487-85.384)0.01910.161 (1.327-77.790)0.02613.414 (1.775-101.359)0.01213.107 (1.719-99.925)0.013
Operative approach (LMRA/OMRA)1.240 (0.426-3.611)0.6930.834 (0.274-2.534)0.7491.233 (0.432-3.516)0.6950.812 (0.269-2.454)0.712